Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New insight into how tissue factor allosterically regulates factor VIIa.

Charles Eigenbrot1, Daniel Kirchhofer

  • 1Department of Protein Engineering, Genentech, Inc., South San Francisco, CA 94080, USA. eigenbrot.c@gene.com

Trends in Cardiovascular Medicine
|February 14, 2002
PubMed
Summary

Factor VIIa (FVIIa) is crucial for blood clotting. Comparing its structure with and without Tissue Factor (TF) reveals how TF regulates FVIIa activity, aiding anticoagulant therapy development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Macrocyclic Peptides as Potent and Selective Inhibitors of Human Neutrophil Serine Protease 4.

Journal of molecular biology·2026
Same author

Development of LRRC15-binding disulfide-constrained peptides for PET imaging of cancer-associated fibroblasts.

Nature communications·2026
Same author

HTRA1-dependent proteolysis induces age-related retinal degeneration and exacerbates choroidal neovascularization.

Disease models & mechanisms·2025
Same author

Pyroptosis of pulmonary fibroblasts and macrophages through NLRC4 inflammasome leads to acute respiratory failure.

Cell reports·2025
Same author

Rapid prediction of key residues for foldability by machine learning model enables the design of highly functional libraries with hyperstable constrained peptide scaffolds.

PLoS computational biology·2024
Same author

Cystine-knot peptide inhibitors of HTRA1 bind to a cryptic pocket within the active site region.

Nature communications·2024

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Factor VIIa (FVIIa) initiates the coagulation cascade, leading to thrombin generation and clot formation.
  • FVIIa is a key target for anticoagulant therapies due to its role in thrombosis and hemostasis.
  • FVIIa activity is regulated by cofactors, substrates, and inhibitors, including Tissue Factor (TF).

Purpose of the Study:

  • To understand the regulatory mechanisms of Factor VIIa (FVIIa) activity.
  • To elucidate the molecular basis of Tissue Factor's (TF) influence on FVIIa's active site.
  • To analyze the structural differences between TF.FVIIa complex and FVII zymogen.

Main Methods:

  • Structural biology
  • X-ray crystallography

Related Experiment Videos

  • Comparative analysis of protein structures

    • Main Results:

    • The 1996 TF.FVIIa structure provided insights into TF's key influence.
    • A recent FVII zymogen structure revealed molecular details of TF's effect on the active site.
    • Unprecedented structural differences between TF.FVIIa and FVII zymogen offer new understanding of FVIIa regulation.

    Conclusions:

    • Structural comparisons illuminate the regulation of Factor VIIa (FVIIa) by Tissue Factor (TF).
    • Understanding these structural differences is critical for developing targeted anticoagulant therapies.
    • This review highlights the significance of structural insights into FVIIa regulation.